Prime Minister Narendra Modi launched a nationwide Human Papillomavirus (HPV) vaccination campaign on February 28, 2026, marking a significant step in India's public health efforts. The initiative, inaugurated from Ajmer, Rajasthan, aims to protect approximately 1.15 crore (11.5 million) 14-year-old girls annually across the country from cervical cancer. The program will offer the vaccine free of cost at government health facilities, with all states and union territories joining the launch virtually.[aslindia+4]
India's Fight Against Cervical Cancer
Cervical cancer stands as the second most common cancer among women in India, posing a serious health risk. Each year, the country reports nearly 80,000 new cases and experiences over 42,000 deaths due to this preventable disease.Persistent infection with high-risk HPV types, particularly types 16 and 18, causes almost all cervical cancer cases. These two HPV types alone account for more than 80 percent of cervical cancer cases in India.The high mortality rate underscores the urgent need for robust preventive measures to safeguard women's health. The disease impacts families and communities, highlighting the broader societal benefit of widespread vaccination.[aslindia+5]
The government's decision to launch this extensive campaign reflects a growing focus on preventive healthcare strategies. By targeting adolescent girls before potential exposure to the virus, India aims to significantly reduce future cases and mortality rates from cervical cancer. This proactive approach aligns with global health recommendations that emphasize early vaccination for maximum protection. The economic and social burden of cervical cancer on affected individuals and the healthcare system is substantial, making prevention a cost-effective and compassionate strategy.
The Nationwide Vaccination Rollout
The nationwide HPV vaccination campaign specifically targets girls who are 14 years old, based on their date of birth. Health Ministry officials confirmed that the vaccination will be voluntary and provided free of cost to all eligible beneficiaries.India will use Gardasil 4, a quadrivalent HPV vaccine, for this drive. This vaccine offers protection against HPV types 16 and 18, which are the primary cancer-causing strains, as well as types 6 and 11.The choice of a single-dose regimen aligns with the recommendations of the World Health Organization's Strategic Advisory Group of Experts on Immunisation, which has cited high efficacy for a single dose in younger age groups.This simplified schedule aims to improve coverage and ease of administration across the vast and diverse Indian landscape.[aslindia+8]
The initial phase of the campaign will run for 90 days, during which eligible girls can receive the vaccine at designated government health centers.Following this intensive campaign period, HPV vaccination will continue under the routine immunization program at health and wellness centers. This ensures sustained access to the vaccine for future cohorts of 14-year-old girls. The government expects to vaccinate approximately 1.15 crore girls turning 14 each year, making it one of the largest public health interventions of its kind.The widespread availability and free access are crucial for equitable healthcare delivery, especially in rural and semi-urban areas.[vajiramandravi+4]
Logistics and Implementation
The vaccination drive will leverage India's extensive public health network to ensure wide accessibility. The single-dose vaccine will be administered at various government health facilities, including Ayushman Arogya Mandirs (Primary Health Centres), Community Health Centres, sub-district and district hospitals, and government medical colleges.This broad distribution network is critical for reaching millions of beneficiaries across all states and union territories. The Union Health Ministry has sent official communications to all states, outlining the program's protocols and urging active participation.[aslindia+4]
To streamline the process, eligible beneficiaries can book appointments at government health centers through the U-Win digital platform, which is similar to the Co-Win system used during the COVID-19 vaccination drive.For those in remote areas or without easy digital access, offline provisions will also be available. Parental or guardian consent is a mandatory requirement before vaccination, and basic identity documentation to verify the child's age may be requested at the centers.Each vaccination session will be overseen by trained medical officers, with robust systems in place for post-vaccination observation and management of any rare adverse events. All vaccination sites will be linked to 24x7 government health facilities to ensure immediate medical support if needed.The program also includes comprehensive vaccine procurement, cold-chain management, and digital beneficiary tracking and monitoring systems to ensure effective implementation and accountability.Public health authorities will oversee operational planning, training of healthcare personnel, and awareness activities to promote vaccination uptake and educate communities about cervical cancer prevention.[vajiramandravi+5]
A Step Towards Women's Empowerment
Prime Minister Modi described the nationwide HPV vaccination campaign as a pivotal step toward empowering India's 'Nari Shakti' (women power) and safeguarding the health of mothers and daughters across the country.He emphasized that a healthy mother empowers her family to confront any crisis with strength, highlighting the government's commitment to women's well-being.The initiative aligns with the government's 'Swastha Nari' (Healthy Woman) mission, aiming to protect adolescent girls against one of the most common yet preventable cancers affecting women in India.[dt+4]
This vaccination drive represents a transformational public health initiative, signifying India's growing emphasis on preventive oncology within its healthcare system. Globally, 160 out of 194 countries include HPV vaccines in their national immunization programs, with 90 countries employing single-dose schedules.India's adoption of a single-dose Gardasil 4 vaccine for this age group positions it among nations utilizing evidence-backed, effective strategies. The long-term impact of this campaign is expected to be a significant reduction in cervical cancer incidence rates in the coming decades, securing a healthier, cancer-free future for millions of young girls across India.[sundayguardianlive+2]
